ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nonalcoholic Steatohepatitis Treatment Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-19Q8347
Home | Market Reports | Health| Health Conditions
Global Nonalcoholic Steatohepatitis Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Nonalcoholic Steatohepatitis Treatment Market Research Report 2025

Code: QYRE-Auto-19Q8347
Report
July 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
VIVUS
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
GENFIT
Gilead

Nonalcoholic Steatohepatitis Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Nonalcoholic Steatohepatitis Treatment Market

Nonalcoholic Steatohepatitis Treatment Market

The global market for Nonalcoholic Steatohepatitis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Nonalcoholic steatohepatitis is a syndrome causes liver damage develops in the individuals who are not alcoholic. The primary mechanisms of nonalcoholic steatohepatitis are obesity, glucose intolerance, metabolic stress, inflammation, dyslipidemia and fibrosis. Nonalcoholic steatohepatitis can develop into cirrhosis and liver cancer. For the diagnosis of the nonalcoholic steatohepatitis, liver biopsy, imaging procedures and various types of blood tests including complete blood count, fasting blood sugar, liver enzyme tests etc. are required. The common nonalcoholic steatohepatitis treatment may include weight loss, type-2 diabetes treatment, a decrease of obesity etc. However, many drugs have been tested for the nonalcoholic steatohepatitis treatment only a few drugs such as vitamin E and pioglitazone showed a positive effect. Other drugs such as ursodeoxycholic acid, metformin, statins, orlistat and pentoxifylline showed only partially positive results.The major elements that can be considered for the pathological protagonists of nonalcoholic steatohepatitis are oxidative stress, altered lipid metabolism adipose and pancreas tissues, bile acids, gut microbiota, bacterial endotoxins, and systemic chronic inflammation.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nonalcoholic Steatohepatitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nonalcoholic Steatohepatitis Treatment.
The Nonalcoholic Steatohepatitis Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nonalcoholic Steatohepatitis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nonalcoholic Steatohepatitis Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Nonalcoholic Steatohepatitis Treatment Market Report

Report Metric Details
Report Name Nonalcoholic Steatohepatitis Treatment Market
CAGR 5%
Segment by Type
  • Solid
  • Liquid
Segment by Application
  • Hospital
  • Diagnostic Center
  • Specialized Clinic
  • Hospital Pharmacy
  • Drug Store
  • Mail Order Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk, Roche, Vivus, Arisaph Pharmaceuticals, Cempra Pharmaceuticals, Galectin Therapeutics, Galmed Pharmaceuticals, Genfit, Gilead
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nonalcoholic Steatohepatitis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Nonalcoholic Steatohepatitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Nonalcoholic Steatohepatitis Treatment Market report?

Ans: The main players in the Nonalcoholic Steatohepatitis Treatment Market are AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk, Roche, Vivus, Arisaph Pharmaceuticals, Cempra Pharmaceuticals, Galectin Therapeutics, Galmed Pharmaceuticals, Genfit, Gilead

What are the Application segmentation covered in the Nonalcoholic Steatohepatitis Treatment Market report?

Ans: The Applications covered in the Nonalcoholic Steatohepatitis Treatment Market report are Hospital, Diagnostic Center, Specialized Clinic, Hospital Pharmacy, Drug Store, Mail Order Pharmacy

What are the Type segmentation covered in the Nonalcoholic Steatohepatitis Treatment Market report?

Ans: The Types covered in the Nonalcoholic Steatohepatitis Treatment Market report are Solid, Liquid

Recommended Reports

Liver Disease Markets

Metabolic & Obesity

Diagnostics & Therapeutics

1 Nonalcoholic Steatohepatitis Treatment Market Overview
1.1 Product Definition
1.2 Nonalcoholic Steatohepatitis Treatment by Type
1.2.1 Global Nonalcoholic Steatohepatitis Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Solid
1.2.3 Liquid
1.3 Nonalcoholic Steatohepatitis Treatment by Application
1.3.1 Global Nonalcoholic Steatohepatitis Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Specialized Clinic
1.3.5 Hospital Pharmacy
1.3.6 Drug Store
1.3.7 Mail Order Pharmacy
1.4 Global Nonalcoholic Steatohepatitis Treatment Market Size Estimates and Forecasts
1.4.1 Global Nonalcoholic Steatohepatitis Treatment Revenue 2020-2031
1.4.2 Global Nonalcoholic Steatohepatitis Treatment Sales 2020-2031
1.4.3 Global Nonalcoholic Steatohepatitis Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Nonalcoholic Steatohepatitis Treatment Market Competition by Manufacturers
2.1 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Nonalcoholic Steatohepatitis Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Nonalcoholic Steatohepatitis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nonalcoholic Steatohepatitis Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nonalcoholic Steatohepatitis Treatment, Product Type & Application
2.7 Global Key Manufacturers of Nonalcoholic Steatohepatitis Treatment, Date of Enter into This Industry
2.8 Global Nonalcoholic Steatohepatitis Treatment Market Competitive Situation and Trends
2.8.1 Global Nonalcoholic Steatohepatitis Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Nonalcoholic Steatohepatitis Treatment Players Market Share by Revenue
2.8.3 Global Nonalcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nonalcoholic Steatohepatitis Treatment Market Scenario by Region
3.1 Global Nonalcoholic Steatohepatitis Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Nonalcoholic Steatohepatitis Treatment Sales by Region: 2020-2031
3.2.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Region: 2020-2025
3.2.2 Global Nonalcoholic Steatohepatitis Treatment Sales by Region: 2026-2031
3.3 Global Nonalcoholic Steatohepatitis Treatment Revenue by Region: 2020-2031
3.3.1 Global Nonalcoholic Steatohepatitis Treatment Revenue by Region: 2020-2025
3.3.2 Global Nonalcoholic Steatohepatitis Treatment Revenue by Region: 2026-2031
3.4 North America Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.4.1 North America Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Nonalcoholic Steatohepatitis Treatment Sales by Country (2020-2031)
3.4.3 North America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.5.1 Europe Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Nonalcoholic Steatohepatitis Treatment Sales by Country (2020-2031)
3.5.3 Europe Nonalcoholic Steatohepatitis Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Nonalcoholic Steatohepatitis Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.7.1 Latin America Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country (2020-2031)
3.7.3 Latin America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2020-2031)
4.1.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2020-2025)
4.1.2 Global Nonalcoholic Steatohepatitis Treatment Sales by Type (2026-2031)
4.1.3 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2020-2031)
4.2 Global Nonalcoholic Steatohepatitis Treatment Revenue by Type (2020-2031)
4.2.1 Global Nonalcoholic Steatohepatitis Treatment Revenue by Type (2020-2025)
4.2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue by Type (2026-2031)
4.2.3 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Nonalcoholic Steatohepatitis Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2020-2031)
5.1.1 Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2020-2025)
5.1.2 Global Nonalcoholic Steatohepatitis Treatment Sales by Application (2026-2031)
5.1.3 Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2020-2031)
5.2 Global Nonalcoholic Steatohepatitis Treatment Revenue by Application (2020-2031)
5.2.1 Global Nonalcoholic Steatohepatitis Treatment Revenue by Application (2020-2025)
5.2.2 Global Nonalcoholic Steatohepatitis Treatment Revenue by Application (2026-2031)
5.2.3 Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Nonalcoholic Steatohepatitis Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Arena Pharmaceuticals
6.2.1 Arena Pharmaceuticals Company Information
6.2.2 Arena Pharmaceuticals Description and Business Overview
6.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.2.5 Arena Pharmaceuticals Recent Developments/Updates
6.3 GSK
6.3.1 GSK Company Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 GSK Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Novo Nordisk
6.4.1 Novo Nordisk Company Information
6.4.2 Novo Nordisk Description and Business Overview
6.4.3 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.4.5 Novo Nordisk Recent Developments/Updates
6.5 Roche
6.5.1 Roche Company Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Roche Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Vivus
6.6.1 Vivus Company Information
6.6.2 Vivus Description and Business Overview
6.6.3 Vivus Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Vivus Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.6.5 Vivus Recent Developments/Updates
6.7 Arisaph Pharmaceuticals
6.7.1 Arisaph Pharmaceuticals Company Information
6.7.2 Arisaph Pharmaceuticals Description and Business Overview
6.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.7.5 Arisaph Pharmaceuticals Recent Developments/Updates
6.8 Cempra Pharmaceuticals
6.8.1 Cempra Pharmaceuticals Company Information
6.8.2 Cempra Pharmaceuticals Description and Business Overview
6.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.8.5 Cempra Pharmaceuticals Recent Developments/Updates
6.9 Galectin Therapeutics
6.9.1 Galectin Therapeutics Company Information
6.9.2 Galectin Therapeutics Description and Business Overview
6.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.9.5 Galectin Therapeutics Recent Developments/Updates
6.10 Galmed Pharmaceuticals
6.10.1 Galmed Pharmaceuticals Company Information
6.10.2 Galmed Pharmaceuticals Description and Business Overview
6.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.10.5 Galmed Pharmaceuticals Recent Developments/Updates
6.11 Genfit
6.11.1 Genfit Company Information
6.11.2 Genfit Description and Business Overview
6.11.3 Genfit Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Genfit Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.11.5 Genfit Recent Developments/Updates
6.12 Gilead
6.12.1 Gilead Company Information
6.12.2 Gilead Description and Business Overview
6.12.3 Gilead Nonalcoholic Steatohepatitis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Gilead Nonalcoholic Steatohepatitis Treatment Product Portfolio
6.12.5 Gilead Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nonalcoholic Steatohepatitis Treatment Industry Chain Analysis
7.2 Nonalcoholic Steatohepatitis Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nonalcoholic Steatohepatitis Treatment Production Mode & Process Analysis
7.4 Nonalcoholic Steatohepatitis Treatment Sales and Marketing
7.4.1 Nonalcoholic Steatohepatitis Treatment Sales Channels
7.4.2 Nonalcoholic Steatohepatitis Treatment Distributors
7.5 Nonalcoholic Steatohepatitis Treatment Customer Analysis
8 Nonalcoholic Steatohepatitis Treatment Market Dynamics
8.1 Nonalcoholic Steatohepatitis Treatment Industry Trends
8.2 Nonalcoholic Steatohepatitis Treatment Market Drivers
8.3 Nonalcoholic Steatohepatitis Treatment Market Challenges
8.4 Nonalcoholic Steatohepatitis Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
VIVUS
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
GENFIT
Gilead
List of Tables
 Table 1. Global Nonalcoholic Steatohepatitis Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Nonalcoholic Steatohepatitis Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Nonalcoholic Steatohepatitis Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Nonalcoholic Steatohepatitis Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Nonalcoholic Steatohepatitis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Nonalcoholic Steatohepatitis Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Nonalcoholic Steatohepatitis Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Nonalcoholic Steatohepatitis Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Nonalcoholic Steatohepatitis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nonalcoholic Steatohepatitis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Nonalcoholic Steatohepatitis Treatment Sales by Region (2020-2025) & (K Units)
 Table 18. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Nonalcoholic Steatohepatitis Treatment Sales by Region (2026-2031) & (K Units)
 Table 20. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Nonalcoholic Steatohepatitis Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Nonalcoholic Steatohepatitis Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Nonalcoholic Steatohepatitis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Nonalcoholic Steatohepatitis Treatment Sales by Country (2020-2025) & (K Units)
 Table 27. North America Nonalcoholic Steatohepatitis Treatment Sales by Country (2026-2031) & (K Units)
 Table 28. North America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Nonalcoholic Steatohepatitis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Nonalcoholic Steatohepatitis Treatment Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Nonalcoholic Steatohepatitis Treatment Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Nonalcoholic Steatohepatitis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Nonalcoholic Steatohepatitis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Nonalcoholic Steatohepatitis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Nonalcoholic Steatohepatitis Treatment Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Nonalcoholic Steatohepatitis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Type (2020-2025)
 Table 51. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Type (2026-2031)
 Table 52. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Application (2020-2025)
 Table 61. Global Nonalcoholic Steatohepatitis Treatment Sales (K Units) by Application (2026-2031)
 Table 62. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Nonalcoholic Steatohepatitis Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Nonalcoholic Steatohepatitis Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Nonalcoholic Steatohepatitis Treatment Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Arena Pharmaceuticals Company Information
 Table 76. Arena Pharmaceuticals Description and Business Overview
 Table 77. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Arena Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
 Table 79. Arena Pharmaceuticals Recent Developments/Updates
 Table 80. GSK Company Information
 Table 81. GSK Description and Business Overview
 Table 82. GSK Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. GSK Nonalcoholic Steatohepatitis Treatment Product
 Table 84. GSK Recent Developments/Updates
 Table 85. Novo Nordisk Company Information
 Table 86. Novo Nordisk Description and Business Overview
 Table 87. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novo Nordisk Nonalcoholic Steatohepatitis Treatment Product
 Table 89. Novo Nordisk Recent Developments/Updates
 Table 90. Roche Company Information
 Table 91. Roche Description and Business Overview
 Table 92. Roche Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Roche Nonalcoholic Steatohepatitis Treatment Product
 Table 94. Roche Recent Developments/Updates
 Table 95. Vivus Company Information
 Table 96. Vivus Description and Business Overview
 Table 97. Vivus Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Vivus Nonalcoholic Steatohepatitis Treatment Product
 Table 99. Vivus Recent Developments/Updates
 Table 100. Arisaph Pharmaceuticals Company Information
 Table 101. Arisaph Pharmaceuticals Description and Business Overview
 Table 102. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
 Table 104. Arisaph Pharmaceuticals Recent Developments/Updates
 Table 105. Cempra Pharmaceuticals Company Information
 Table 106. Cempra Pharmaceuticals Description and Business Overview
 Table 107. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
 Table 109. Cempra Pharmaceuticals Recent Developments/Updates
 Table 110. Galectin Therapeutics Company Information
 Table 111. Galectin Therapeutics Description and Business Overview
 Table 112. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Galectin Therapeutics Nonalcoholic Steatohepatitis Treatment Product
 Table 114. Galectin Therapeutics Recent Developments/Updates
 Table 115. Galmed Pharmaceuticals Company Information
 Table 116. Galmed Pharmaceuticals Description and Business Overview
 Table 117. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis Treatment Product
 Table 119. Galmed Pharmaceuticals Recent Developments/Updates
 Table 120. Genfit Company Information
 Table 121. Genfit Description and Business Overview
 Table 122. Genfit Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Genfit Nonalcoholic Steatohepatitis Treatment Product
 Table 124. Genfit Recent Developments/Updates
 Table 125. Gilead Company Information
 Table 126. Gilead Description and Business Overview
 Table 127. Gilead Nonalcoholic Steatohepatitis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Gilead Nonalcoholic Steatohepatitis Treatment Product
 Table 129. Gilead Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Nonalcoholic Steatohepatitis Treatment Distributors List
 Table 133. Nonalcoholic Steatohepatitis Treatment Customers List
 Table 134. Nonalcoholic Steatohepatitis Treatment Market Trends
 Table 135. Nonalcoholic Steatohepatitis Treatment Market Drivers
 Table 136. Nonalcoholic Steatohepatitis Treatment Market Challenges
 Table 137. Nonalcoholic Steatohepatitis Treatment Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nonalcoholic Steatohepatitis Treatment
 Figure 2. Global Nonalcoholic Steatohepatitis Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nonalcoholic Steatohepatitis Treatment Market Share by Type: 2024 & 2031
 Figure 4. Solid Product Picture
 Figure 5. Liquid Product Picture
 Figure 6. Global Nonalcoholic Steatohepatitis Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Nonalcoholic Steatohepatitis Treatment Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Diagnostic Center
 Figure 10. Specialized Clinic
 Figure 11. Hospital Pharmacy
 Figure 12. Drug Store
 Figure 13. Mail Order Pharmacy
 Figure 14. Global Nonalcoholic Steatohepatitis Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Nonalcoholic Steatohepatitis Treatment Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Nonalcoholic Steatohepatitis Treatment Sales (2020-2031) & (K Units)
 Figure 17. Global Nonalcoholic Steatohepatitis Treatment Average Price (US$/Unit) & (2020-2031)
 Figure 18. Nonalcoholic Steatohepatitis Treatment Report Years Considered
 Figure 19. Nonalcoholic Steatohepatitis Treatment Sales Share by Manufacturers in 2024
 Figure 20. Global Nonalcoholic Steatohepatitis Treatment Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Nonalcoholic Steatohepatitis Treatment Players: Market Share by Revenue in Nonalcoholic Steatohepatitis Treatment in 2024
 Figure 22. Nonalcoholic Steatohepatitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Nonalcoholic Steatohepatitis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2020-2031)
 Figure 25. North America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2020-2031)
 Figure 26. United States Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2020-2031)
 Figure 29. Europe Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Nonalcoholic Steatohepatitis Treatment Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Region (2020-2031)
 Figure 37. China Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Nonalcoholic Steatohepatitis Treatment Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Nonalcoholic Steatohepatitis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Nonalcoholic Steatohepatitis Treatment by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Nonalcoholic Steatohepatitis Treatment by Type (2020-2031)
 Figure 58. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Nonalcoholic Steatohepatitis Treatment by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Nonalcoholic Steatohepatitis Treatment by Application (2020-2031)
 Figure 61. Global Nonalcoholic Steatohepatitis Treatment Price (US$/Unit) by Application (2020-2031)
 Figure 62. Nonalcoholic Steatohepatitis Treatment Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Non Alcoholic Steatohepatitis Treatment Market Research Report 2025
Global Non Alcoholic Steatohepatitis NASH Treatment Market Insights Forecast to 2030
Non Alcoholic Steatohepatitis Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Alcoholic Steatohepatitis Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nonalcoholic Steatohepatitis NASH Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Alcoholic Steatohepatitis NASH Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non Alcoholic Fatty Liver Disease Treatment Market Research Report 2024
Liver Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Non alcoholic Steatohepatitis NASH Biomarkers Market Research Report 2024
Alcoholic Liver Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non alcoholic Steatohepatitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nonalcoholic Steatohepatitis Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NASH Non alcoholic Steatohepatitis Biomarkers Market Research Report 2024
Fatty Liver Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hepatic Encephalopathy Drug Market Research Report 2024
Global Alcoholic Hepatiti Drug Market Research Report 2024
Drugs for Fatty Acid Oxidation Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liver Diseases Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hypertriglyceridemia Treatment Market Research Report 2025

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions